Australian reproductive-technology company Virtus Health will have to pay some of the legal costs incurred by the country’s competition regulator in the watchdog’s efforts to block Virtus’ acquisition of industry peer, Helius-owned Adora Fertility. In a partial win for the Australian Competition & Consumer Commission, or ACCC, today, Federal Court of Australia